Hopkins, A. M., Rathod, A. D., Rowland, A., Kichenadasse, G., & Sorich, M. J. (2020). Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: Pooled analysis of clinical trials. BMC Cancer.
Citação norma ChicagoHopkins, Ashley M., Akash D. Rathod, Andrew Rowland, Ganessan Kichenadasse, and Michael J. Sorich. "Risk Factors for Severe Rash With Use of Vemurafenib Alone or in Combination With Cobimetinib for Advanced Melanoma: Pooled Analysis of Clinical Trials." BMC Cancer 2020.
Citação norma MLAHopkins, Ashley M., et al. "Risk Factors for Severe Rash With Use of Vemurafenib Alone or in Combination With Cobimetinib for Advanced Melanoma: Pooled Analysis of Clinical Trials." BMC Cancer 2020.